| # | Drug | Count |
|---|---|---|
| 0 | BECLOMETHASONE DIPROPIONATE HFA | 3 |
| 1 | ALBUTEROL SULFATE | 2 |
| 2 | BUPROPION | 2 |
| 3 | DOLUTEGRAVIR SODIUM | 2 |
| 4 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 |
| 5 | FEXOFENADINE HYDROCHLORIDE | 2 |
| 6 | LEVONORGESTREL | 2 |
| 7 | LISDEXAMFETAMINE DIMESYLATE | 2 |
| 8 | ACYCLOVIR | 1 |
| 9 | ARIPIPRAZOLE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLOBETASOL PROPIONATE CREAM USP, 0.05% | 1 | 0.0101 |
| 1 | BECLOMETHASONE DIPROPIONATE HFA | 3 | 0.0010 |
| 2 | DOLUTEGRAVIR SODIUM AND LAMIVUDINE | 1 | 0.0003 |
| 3 | DOLUTEGRAVIR SODIUM | 2 | 0.0002 |
| 4 | GLECAPREVIR AND PIBRENTASVIR | 1 | 0.0001 |
| 5 | FEXOFENADINE HYDROCHLORIDE | 2 | 0.0001 |
| 6 | LISDEXAMFETAMINE DIMESYLATE | 2 | 0.0001 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0000 |
| 8 | ERGOCALCIFEROL | 1 | 0.0000 |
| 9 | NALTREXONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 4 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 7 | Arteriolar Vasodilator [EPC] | 1 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |